TY  - CONF

T1  - The ZO-FAST trial: zoledronic acid effectively inhibits aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 24 month BMD results

JO  - BREAST CANCER RESEARCH AND TREATMENT

PY  - 2007/12/01

AU  - Deboerr R

AU  - Eidtmann H

AU  - Pinotti G

AU  - Miller J

AU  - Schenk N

AU  - Dias R

AU  - Coleman R

ED  - 

VL  - 106

SP  - S36

EP  - S36

Y2  - 2025/10/10

ER  -